Breast cancers are categorized into ER+, ER+/HER2-, HER2+ and Triple-negative subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.